Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Schuster

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
European Journal of Medicinal Chemistry|July 13, 2019
Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptorsGabriele Murineddu, Cecilia Gotti, Battistina Asproni, et al.
European Journal of Medicinal Chemistry|November 13, 2016
Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenaseAntonella Peduto, Maria Scuotto, Verena Krauth, et al.
Journal of Natural Products|March 7, 2014
Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gammaEva-Maria Pferschy-Wenzig, Atanas G Atanasov, Clemens Malainer, et al.
Journal of Natural Products|October 27, 2018
Stereoselective Synthesis of the Isomers of Notoincisol A: Assigment of the Absolute Configuration of this Natural Product and Biological EvaluationLukas Rycek, Vincenzo Ticli, Jakob Pyszkowski, et al.
Molecular Pharmacology|January 13, 2010
Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gammaNanang Fakhrudin, Angela Ladurner, Atanas G Atanasov, et al.
Cancers|August 1, 2020
Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate CancerMona Kafka, Fabian Mayr, Veronika Temml, et al.
Journal of Medicinal Chemistry|January 16, 2009
Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflowPatrick Markt, Clemens Feldmann, Judith Maria Rollinger, et al.
Atherosclerosis|August 9, 2011
Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer proteinKristina Duwensee, Stefan Schwaiger, Ivan Tancevski, et al.
Bioorganic & Medicinal Chemistry|October 22, 2011
Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidumUlrike Grienke, Judit Mihály-Bison, Daniela Schuster, et al.
Journal of Molecular and Cellular Cardiology|August 8, 2016
Leoligin, the major lignan from Edelweiss, inhibits 3-hydroxy-3-methyl-glutaryl-CoA reductase and reduces cholesterol levels in ApoE-/- miceBernhard Scharinger, Barbara Messner, Adrian Türkcan, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
European Journal of Medicinal Chemistry|July 13, 2019
Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptorsGabriele Murineddu, Cecilia Gotti, Battistina Asproni, et al.
European Journal of Medicinal Chemistry|November 13, 2016
Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenaseAntonella Peduto, Maria Scuotto, Verena Krauth, et al.
Journal of Natural Products|March 7, 2014
Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gammaEva-Maria Pferschy-Wenzig, Atanas G Atanasov, Clemens Malainer, et al.
Journal of Natural Products|October 27, 2018
Stereoselective Synthesis of the Isomers of Notoincisol A: Assigment of the Absolute Configuration of this Natural Product and Biological EvaluationLukas Rycek, Vincenzo Ticli, Jakob Pyszkowski, et al.
Molecular Pharmacology|January 13, 2010
Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gammaNanang Fakhrudin, Angela Ladurner, Atanas G Atanasov, et al.
Cancers|August 1, 2020
Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate CancerMona Kafka, Fabian Mayr, Veronika Temml, et al.
Journal of Medicinal Chemistry|January 16, 2009
Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflowPatrick Markt, Clemens Feldmann, Judith Maria Rollinger, et al.
Atherosclerosis|August 9, 2011
Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer proteinKristina Duwensee, Stefan Schwaiger, Ivan Tancevski, et al.
Bioorganic & Medicinal Chemistry|October 22, 2011
Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidumUlrike Grienke, Judit Mihály-Bison, Daniela Schuster, et al.
Journal of Molecular and Cellular Cardiology|August 8, 2016
Leoligin, the major lignan from Edelweiss, inhibits 3-hydroxy-3-methyl-glutaryl-CoA reductase and reduces cholesterol levels in ApoE-/- miceBernhard Scharinger, Barbara Messner, Adrian Türkcan, et al.
Pageof 17